The Ketamine StartUp Podcast

Hosted by Ketamine StartUp

Business Entrepreneurship Education Health FitnessInterviews guests

Website RSS feed LinkedIn Facebook YouTube

Episodes

Latest episode

Aug 2026

Language

About the show

Welcome to the Ketamine StartUp Podcast! This is the FIRST podcast dedicated to entrepreneurial medical professionals who want to learn more about providing ketamine therapy, run a business, marketing, and more. We are Sam and Kim Ko, two board certified physicians who have ventured into the ketamine therapy world. We’ve learned a lot of lessons, taught many clinicians like yourself, and luckily made a few friends along the way. In this podcast we share our experience and knowledge, plus that of the ketamine industry pioneers and leaders in our interviews. If you’re ready to boldly go where a few medical professionals have gone before, download and listen to our podcast today

Listen to episodes

60 recent

September 1, 2026Episode 6431 min

Episode 64 - What the Research Says About Ketamine for Postpartum Depression

Clinical Disclaimer: This episode is for educational purposes for licensed healthcare professionals and is not individual medical advice. Ketamine and esketamine are not FDA‑approved for preventing or treating postpartum depression; any use in this population is off‑label and should be considered investigational and undertaken only with appropriate training, collaboration, and adherence to current standards of care. Postpartum depression affects roughly 10 to 20 percent of mothers and remains one of the most undertreated conditions in medicine. As public awareness of maternal mental health grows, providers in the ketamine and psychedelic therapy space are increasingly asking: is there a role for ketamine or esketamine here? This episode is our evidence-based answer to that question. We walk through the current clinical literature on ketamine and esketamine for perinatal depression, drawing on randomized controlled trials, meta-analyses, and expert commentary from institutions including the Center for Women's Mental Health at Massachusetts General Hospital. The research landscape is more nuanced than most providers realize, and understanding it clearly matters both for patient conversations and for how you think about your practice's scope. One distinction shapes everything that follows in this episode, and it's an important one: virtually all of the existing trial data involves perioperative prevention in cesarean delivery populations, not outpatient treatment of established postpartum depression . Knowing what the evidence actually supports and where the gaps remain is essential context for any provider working in this space. What You’ll Gain · A clear breakdown of what current ketamine and esketamine trials actually show for postpartum depression prevention , and what limited data exist for treatment . · An understanding of why racemic ketamine and esketamine tell different stories in the peripartum literature. · The key ethical and practical considerations for any provider thinking about this population. · An honest framework for how to talk with patients who ask about ketamine for postpartum depression. · Context on what the research gaps mean for where this field is heading. Review the research behind this episode, including full citations for every study discussed, in the Clinical References and Further Reading . 📖 Prefer to read? We turned this episode into a full blog post with structured tables comparing the racemic ketamine and esketamine evidence side by side, plus a research gaps summary you can reference and share with your team: Read the Blog Post Episode 64 show notes: 00:00:06 Episode Introduction 00:02:02 Clinical Context: Defining PPD, Postpartum Psychosis, and Perinatal Depression 00:03:34 Prevalence, Public Health Burden, and Why Cesarean Delivery Matters Here 00:04:40 Why Ketamine and Esketamine Are Conceptually Interesting in This Population 00:05:38 Prevention vs. Treatment: A Critical Framing Point Before the Research 00:06:32 Racemic Ketamine in the Peripartum Setting: Mixed and Conflicting Signals 00:09:22 What the Meta-Analyses Tell Us: Darwish et al. 2025 and Li et al. 2024 00:11:18 Bottom Line on Racemic Ketamine in the Peripartum Setting 00:12:05 Esketamine: Why It May Outperform Racemic and Why This Is Not About Spravato 00:13:32 The Esketamine Trials: From Early Signals to the 2024 BMJ Landmark Study 00:18:51 Treatment vs. Prevention: What About Established PPD? 00:21:29 Ethical and Practical Considerations 00:21:40 Lactation and Infant Exposure 00:22:14 Neurodevelopment Data: The Long-Term Unknown 00:22:35 Informed Consent in the Peripartum Period 00:23:04 The Tension Between Rapid Relief and Premature Clinical Adoption 00:24:10 Clinical Takeaways, Research Gaps, and What Cautious Optimism Looks Like in Practice 00:24:27 What the Evidence Supports: Esketamine Summary 00:25:23 What the Evidence Does Not Yet Support: Outpatient PPD Use 00:25:41 Bottom Line on Racemic Ketamine: Summary 00:26:07 Five Research Gaps the Field Needs to Address 00:27:56 What This Data Means for Ketamine Therapy Providers Right Now 00:30:03 Closing Remarks Thanks for Listening 📝 For Complete show notes along with the the research behind this episode, including full citations for every study discussed, please visit http://www.ketaminestartup.com/podcast/episode-064

August 17, 2026Episode 6321 min

Episode 63 - Opening a Ketamine Clinic: An Unconventional Path for Emergency Physicians (Episode From The Vault)

In this episode from the vault, we’re going back to when Sam gave a presentation at the American College of Emergency Physicians (ACEP) Scientific Assembly, making the case for why emergency physicians and clinicians are uniquely positioned to successfully practice in the ketamine therapy space. This is not a generic overview of ketamine. It is a frank, evidence-based conversation directed at clinicians who are feeling the weight of burnout, decreased autonomy, and a healthcare system that is asking more while giving less in return. Sam walks through the science, the mechanism, the financial realities, and the deeper question of purpose that every provider should sit with before taking the leap. If you have ever wondered whether your emergency medicine training could translate into something more fulfilling, this episode makes a compelling and well-researched argument that it can. What You'll Gain: • A clear picture of the mental health and chronic pain crisis driving demand for ketamine therapy, and why the current standard of care is falling short for so many patients • A walk through the key clinical studies supporting IV ketamine for depression, anxiety, PTSD, and chronic pain, including the landmark 2023 New England Journal of Medicine trial comparing ketamine to ECT • An honest look at the mechanism of action behind ketamine therapy, from NMDA receptor antagonism to neuroplasticity and BDNF, explained in language that makes clinical sense • Why emergency physicians bring a uniquely transferable skill set to the ketamine therapy space, and how that advantage plays out in practice • The financial and emotional realities of running a ketamine clinic, including what Sam wishes more providers understood before they opened their doors • Why knowing your why is the single most important thing you can do before starting a ketamine practice, and how it will carry you through the inevitable hard moments Episode 63 show notes: 00:00:00 Teaser: "This is the why, the purpose, the motivation." 00:00:34 Episode Introduction and Overview 00:01:45 The Mental Health Crisis: Why This Work Matters Now 00:03:48 Burnout and the Changing Landscape of Emergency Medicine 00:04:43 Why EM Physicians Are Uniquely Positioned for Ketamine Therapy 00:05:02 The Clinical Evidence for Depression: From the Berman 2000 Study to the 2023 NEJM Trial 00:07:25 The Clinical Evidence for Anxiety: Dr. Paul Glue's Escalating Dose Study 00:08:20 The Clinical Evidence for PTSD: Single and Multiple Infusion Data 00:09:41 The Clinical Evidence for Chronic Pain: What Works and What Doesn't 00:10:55 Mid-Episode Ad: Free Ketamine Startup Checklist 00:11:44 How Ketamine Works: NMDA Receptor Antagonism and Glutamate 00:12:19 Multi-Receptor Action, Neuroplasticity, and BDNF 00:13:30 Beyond the Mechanism: The Experiential Dimension of Ketamine 00:14:40 The EM Skill Set Advantage: Clinical Experience, Procedures, and Scheduling Flexibility 00:15:24 Emergency Medicine Is a Mindset, Not a Location 00:15:53 Before the How, There Is the Why 00:16:39 The Toxic Waste Pool: A Story About Purpose and Motivation 00:17:23 The Financial Reality: Don't Open a Clinic for the Money 00:18:14 Why You Should Open a Ketamine Clinic: Purpose, Autonomy, and Saving Lives 00:18:55 Patient Testimonials: In Their Own Words 00:20:17 Outro Thanks for listening 🎥 Prefer to watch? This episode was originally a live conference presentation with slides covering the clinical studies, mechanisms of action, and other helpful visuals. The YouTube version brings all of that to life: Watch Episode 063 on YouTube 📖 More of a reader? We turned this presentation into a full blog post covering the clinical evidence, why your EM training is an unfair advantage, the financial reality nobody talks about enough, and what patients say when the treatment works: Read the Blog Post 📝 Complete show notes with resources and links, please visit https://www.ketaminestartup.com/podcast/episode-063 Follow us on Linkedin Ketamine StartUp Website YouTube 🚀Want to fast track launching your ketamine clinic? If so, download our free checklist .

August 3, 2026Episode 621 hr 5 min

Episode 62 - What It Takes to Be the First: Building a Ketamine Practice in a Resistant Healthcare System with Dr. Lowan Stewart

Dr. Lowan Stewart is not just someone who opened a ketamine clinic. He is someone who built the infrastructure for an entire country to access it. In this conversation, Sam sits down with Dr. Stewart, an emergency physician who co-founded the first ketamine clinic in New Mexico in 2016, brought ketamine therapy to Norway two years later, established the first public ketamine treatment unit in Scandinavia, and played a central role in Norway becoming the first country in the world to approve national public reimbursement for off-label ketamine in treatment-resistant depression. What makes Dr. Stewart's story particularly resonant for our audience is how familiar the starting point will feel. An EM physician who loved his work but felt the limits of what emergency medicine could do for the river of suffering flowing through the department. A side project that became a calling. An uphill battle against institutional skepticism that most providers in this space will recognize immediately. He also brings a perspective on the future of psychedelic medicine that is worth hearing. His argument is straightforward: ketamine is not just a treatment. It is the infrastructure that will make everything else, psilocybin, MDMA, and what comes after, possible in clinical and public health settings. Getting ketamine right now is how the field prepares for what is coming next. This is a wide-ranging conversation covering career pivots, pioneering in resistant systems, the mechanics of moving a national healthcare system, and the daily reality of doing work that genuinely transforms lives. What you’ll gain: • The full arc of Dr. Stewart's career pivot from emergency medicine to ketamine therapy, including what pushed him toward something with more systemic and sustainable impact than the ER could offer • A firsthand account of what it actually looks like to be the first mover in a resistant healthcare system, from opening the first ketamine clinic in New Mexico to fighting a formal complaint from the Norwegian Psychiatric Association • How Dr. Stewart built the first public ketamine treatment unit in Scandinavia and the strategy behind getting ten major Norwegian hospitals to implement ketamine therapy simultaneously through a multi-site clinical trial • What Norway's landmark decision to become the first country in the world to approve national public reimbursement for off-label ketamine in treatment-resistant depression means for the global field and what other countries can learn from it • Why Dr. Stewart believes ketamine is not just a treatment but the infrastructure that will determine how ready clinical and public health systems are when psilocybin, MDMA, and other psychedelic medicines arrive • His honest reflection on why this work is worth it, including what it feels like to shift from focusing on the quantity of life in the ER to focusing on the quality of life in ketamine therapy Episode 62 show notes: 00:00:00 Teaser: "Once somebody says, 'I'm alive today because of this treatment,' you can't not do it." 00:00:24 Episode Introduction 00:02:19 Sam Welcomes Dr. Lowan Stewart 00:02:53 Background Overview: Emergency Medicine, Norway, and the Journey to Ketamine 00:08:56 Why Neuroscience: Starting an MD-PhD and the Rat Brains Advice 00:10:09 From Space Medicine Dreams to Emergency Medicine Reality 00:12:14 The Decision Point: Going Away from EM or Toward Something New? 00:15:37 Opening the First Ketamine Clinic in New Mexico: What the Ketamine World Looked Like in 2016 00:17:55 Bringing Ketamine to Norway: Opening Axon Clinic in 2018 00:20:06 Approaching the Norwegian Psychiatric Association and Health Department with the Data 00:26:40 Psychiatrist Skepticism: "I Don't Know What to Do with These Patients If They're Fine" 00:28:29 The Formal Complaint from the Norwegian Psychiatric Association 00:31:23 Establishing the First Public Ketamine Treatment Unit in Scandinavia 00:34:34 Axon Clinic's Acquisition by Awaken Life Sciences and the Ukraine War Impact 00:40:18 Norway's Landmark Approval: National Public Reimbursement for Off-Label Ketamine 00:44:20 The Multi-Site RCT Strategy: Implementing Ketamine Across Ten Major Norwegian Hospitals 00:50:17 Why Ketamine Gets Overlooked at Psychedelic Conferences and Why That Needs to Change 00:55:14 One Piece of Advice for Any EM Physician or Clinician Considering This Pivot 00:58:34 Rapid-Fire Questions 00:59:07 How Dr. Stewart De-Stresses: Cold Ocean Swims and Sauna in Norway 01:02:17 How to Connect with Dr. Lowan Stewart 01:04:03 Episode Ending Thanks for listening Connect with Dr. Stewart at: Clinic Website - Axonklinikken http://axon.no/ Email: lowan@axon.no Linkedin: https://www.linkedin.com/in/lowan-stewart-27349616/ 📝 Complete show notes with resources and links, please visit https://www.ketaminestartup.com/podcast/episode-062

July 21, 2026Episode 6114 min

Episode 61 – Is Your Clinic Asystolic? The Marketing Framework Every Ketamine Provider Needs (Soundbites from the Vault)

In this Soundbite from the Vault, we're revisiting a carefully selected segment from a live conference presentation we gave to a room full of ketamine therapy specialists, walking through the exact marketing framework we've built and refined over the years. Not familiar with our Soundbites from the Vault? These are shorter, standalone segments from earlier episodes that we think are worth revisiting: easy to digest and immediately relevant to your practice. This one is a little different from our typical guest interviews. It's practical, visual, and built for providers who are doing their own marketing, outsourcing it, or using AI tools to help, and who want to understand the thinking behind it all. Because the framework matters regardless of who's doing the work. We cover the full ACC model: awareness, consideration, and conversion, breaking down exactly where every marketing effort you're making fits inside it. Then we get into organic content, what it actually is, how to create it sustainably without burning out, and our Venn diagram approach to figuring out what to talk about in the first place. And if you stay to the end, you'll hear why your clinic's online presence may be one of its most important vital signs. If your marketing has ever felt scattered, reactive, or disconnected from any real goal, this framework gives you the language and the structure to change that. What You'll Gain: · A clear understanding of the medical marketing funnel and how every marketing effort you make maps to one of its three layers: awareness, consideration, or conversion · The ACC framework explained through a relatable analogy that makes the patient journey easy to visualize and remember · A practical Venn diagram approach for figuring out what content to actually create, where what your patients want to know meets what is authentic to you · A simple content creation system that turns one video into a blog, social media posts, and micro content across platforms · Why your clinic's online presence is one of its most telling vital signs, and what asystole, bradycardia, and atrial fibrillation have to do with your Instagram account Episode 61 show notes: 00:00:00 Teaser: "What you want to be is in normal sinus rhythm…" 00:00:19 Episode Introduction 00:01:43 What Is the Medical Marketing Funnel and Why Should You Care? 00:02:08 The ACC Framework: Awareness, Consideration, and Conversion Explained 00:02:35 Awareness: How Patients First Discover You and What Content Helps Them Find You 00:03:45 Consideration: Why Patients Compare Their Options and How to Stand Out 00:04:24 Conversion: Making It Easy and Frictionless for Patients to Say Yes 00:05:13 Want More Patients? Start by Growing the Top of the Funnel 00:06:34 What Is Organic Content and How Is It Different from Paid Advertising? 00:07:58 The Venn Diagram: Finding the Sweet Spot Between What Patients Want and What's Authentic to You 00:08:14 What Your Patients Actually Want to Know 00:08:29 Why Authenticity Is What Turns Generic Content Into Content That Connects 00:10:00 From One Video to a Blog, Social Posts, and Micro Content: The Content Creation System 00:12:02 Is Your Clinic Asystolic? Why Organic Content Is One of Your Most Important Vital Signs 00:13:41 Episode Ending and Resources Thanks for listening Selected Links From the Episode: Want to go deeper? This soundbite comes from Episode 035 – The Medical Marketing Funnel for Ketamine Clinics , where we cover the full conversation including a deep dive into the newsletter as a standalone marketing tool for your practice. 🎥 The marketing funnel, the Venn diagram, and the organic content framework are all significantly easier to follow when you can see the slides. Check out the full Episode 035 on YouTube to watch the original presentation with all the visuals included: Watch Episode 035 on YouTube 📝 Complete show notes with resources and links, please visit https://www.ketaminestartup.com/podcast/episode-061 Follow us on Linkedin Ketamine StartUp Website YouTube 🚀 Want to fast track launching your ketamine clinic? If so, download our free checklist .

July 7, 2026Episode 6016 min

Episode 60 – Why Music Is More Than Background Noise in Ketamine Therapy (Soundbites from the Vault)

We're taking it a little easy in July, and in the spirit of that, we're launching something new: Soundbites from the Vault. These are shorter, standalone segments from earlier episodes that we think are worth revisiting, easy to digest, and immediately relevant to your practice. For our first soundbite, we're revisiting one of our favorite conversations from Episode 32 with Steve Gelberg, author of Tuning In: Experiencing Music in Psychedelic States. Steve spent years researching the intersection of music and psychedelic-assisted therapy, and what he shares here has direct practical implications for how you're running your ketamine sessions. This segment gets into something most providers haven't thought deeply about: music isn't just filling the silence. It's doing active therapeutic work, from calming a patient's first fear response as ketamine comes on, to opening access to the subconscious material that makes treatment meaningful. Steve also covers the practical side, including what types of music to use, why lyrics are generally a problem, and how to think about the classical versus ambient debate without getting dogmatic about it. If you've been using the same playlist since you opened, this one is worth 15 minutes of your time. What You'll Gain: · Why music and psychedelics share a unique therapeutic synergy rooted in how both interact with emotional and subconscious experience · How the right music can calm the ego's fear response during the onset of a ketamine session and support deeper therapeutic outcomes · Why lyrics are generally avoided during psychedelic-assisted therapy and what instrumental genres tend to work best · The case for neoclassical music as a middle ground between classical and ambient for ketamine sessions · How to think about patient-chosen music versus therapist-curated playlists, and why avoiding dogma matters more than finding the perfect answer Episode 60 show notes: 00:00:00 Teaser: "The right kind of music…” 00:00:33 Episode Introduction and Soundbites from the Vault Launch 00:01:32 The Shared Ontology of Music and Psychedelics 00:03:37 How Psychedelics Open the Emotional Sphere of Consciousness 00:04:41 The Unique Therapeutic Synergy Between Music and Ketamine 00:05:08 What Music Is Actually Doing at the Onset of a Ketamine Session 00:05:55 How Music Helps Surface the Root of Depression, Phobias, and Trauma 00:07:01 Music as an Ancient and Primal Human Tool: Lullabies and Soothing 00:08:25 The Case for Healing Female Voices in Psychedelic-Assisted Therapy 00:09:41 How to Choose Music for Ketamine Sessions: A Provider's Guide 00:10:23 The Classical vs. Ambient Debate: Origins and Context 00:11:36 Why Lyrics Are Generally Avoided During Ketamine Therapy 00:12:39 Neoclassical Music: The Best of Both Classical and Ambient 00:13:39 Avoiding Agitating or Overly Dramatic Music in Sessions 00:14:11 Patient-Chosen vs. Therapist-Curated Playlists 00:15:12 Why There Should Be No Dogma Around Music Selection 00:15:48 Episode Ending and Resources Thanks for listening 📝 Want Steve's exact playlists and a link to his book? Everything is in the show notes at https://www.ketaminestartup.com/podcast/episode-060#links

June 23, 2026Episode 5959 min

Episode 59 - Rethinking Set and Setting: Dr. Roberto Malinow's Revolutionary Hypothesis on How Ketamine Actually Works

This week, host Sam Ko goes upstream from our usual clinical and business topics to sit down with Dr. Roberto Malinow, emeritus professor at UC San Diego, member of both the National Academy of Sciences and the National Academy of Medicine, and one of the world's leading researchers on synaptic plasticity and NMDA receptor biology. His work has been cited more than 30,000 times, and his recent perspective piece takes a very different view of what's actually happening during a ketamine infusion. The core of this conversation is his hypothesis that ketamine works by selectively weakening hyperactive brain circuits, but only the ones actively firing while the drug is on board. It's a finding that raises some genuinely uncomfortable questions about the standard set and setting approach, and points to chronic pain treatment as a practical place to start testing these ideas clinically. You'll also hear about the brain's "disappointment center," the lateral habenula, and why it may be hyperactive in depression, the Stanford anesthesia study and what it suggests about brain activity during treatment, and a wide ranging look at consciousness, optogenetics, the gut-brain connection, and what basic science still doesn't fully understand about how psychiatric drugs work. What You'll Learn in This Episode · Revolutionary ketamine mechanism - How Dr. Malinow's hypothesis suggests ketamine works by weakening hyperactive brain circuits, but only when those specific circuits are actively firing during treatment · The disappointment center concept - Understanding the lateral habenula as the brain's disappointment center that inhibits dopamine and may be hyperactive in depression, serving an evolutionary purpose in reinforcement learning · Challenge to set and setting orthodoxy - How activating negative thoughts or painful experiences could possibly enhance therapeutic outcomes · Neuroplasticity fundamentals - How synapses can be rapidly modified and why NMDA receptors are crucial for both strengthening and weakening neural pathways, forming the basis for learning and memory · Rapid vs. delayed therapeutic effects - Why ketamine can work almost immediately while traditional antidepressants take weeks, and what this reveals about different mechanisms of action · Chronic pain treatment implications - How activating pain circuits during ketamine infusions might be more effective than current protocols, and why chronic pain could be the ideal testing ground for this hypothesis · Basic science translation - How laboratory findings about synaptic plasticity and NMDA receptors connect to real-world therapeutic applications in depression, PTSD, and pain management · Optogenetics technology - How scientists can now deliver light-sensitive proteins to specific neurons, allowing precise activation or inactivation of brain circuits to study behavior and memory · Memory manipulation research - Fascinating studies showing how specific memories can be turned on and off using targeted brain stimulation, with implications for trauma and addiction treatment · Consciousness and synaptic function - Exploring the complex relationship between individual neurons and higher-order brain functions, and why bridging these levels remains challenging Episode 59 show notes: 00:00:00 Teaser: Those hyperactive circuits… 00:00:24 Episode Introduction and Guest Overview 00:01:12 Sam Introduces and Welcomes Dr. Roberto Malinow 00:02:41 Background: From Reed College to The MD/PhD Path 00:05:17 Why Basic Science Won Out Over Clinical Medicine 00:06:06 The Lecture That Started It All: Professor Rodolfo Llinás and Synapses 00:06:51 How Ketamine Interacts with the NMDA Receptor 00:07:47 The "Disappointment Center": What the Lateral Habenula Does and Why It Matters in Depression 00:09:16 The Standard Set and Setting Approach in Outpatient Ketamine Clinics 00:10:12 The Three-Part Hypothesis: Neuroplasticity, Hyperactive Circuits, and Negative Thoughts 00:11:49 Written Exposure Therapy and PTSD: Priming Circuits Before the Infusion 00:12:53 Chronic Pain as the Easier Testing Ground for the Hypothesis 00:14:20 Activating the Pain Pathways During a Ketamine Infusion 00:17:23 The Anesthesia Study (Heifets/Stanford): Why the Brain Needs to Be Active 00:18:48 What Would a Human Study Design Actually Look Like? 00:20:41 Animal Study Evidence Supporting the Active-Stimulus Hypothesis 00:21:33 Zooming Out: Synapses, Consciousness, and the Shakespeare Analogy 00:23:18 Optogenetics Explained: Using Light to Control Specific Neurons 00:27:31 What Don't We Understand About Depression? 00:28:29 Lateral Habenula in Animal Depression Models and Dr. Malinow's Own Experiments 00:29:13 The Dystopian Scenario: Using Ketamine-Like Drugs to Wipe Out Ideas 00:31:31 Common Misconceptions Clinicians Have About Synapses 00:32:47 What Surprised Dr. Malinow Most About Studying Synapses 00:35:15 Why Ketamine Works Rapidly While SSRIs Take Weeks 00:37:30 The "Party Trick": Learning Is Neuroplasticity in Real Time 00:39:13 NMDA Receptors and Their Role in Learning and Memory 00:39:47 Optogenetics Research: Turning Fear Memories On and Off in Animals 00:42:08 Glutamate: 90% of Synaptic Transmission Explained 00:43:55 Synapses in the Gut: The Enteric Nervous System 00:45:58 The Gut-Brain Connection and Future Research 00:46:23 Papers Worth Reading in the Ketamine Space 00:47:50 The Psychedelic Renaissance: Psilocybin, the Disappointment Center, and What's Next 00:50:20 Could the Activation Hypothesis Apply to Psilocybin and MDMA as Well? 00:52:57 Rapid-Fire Questions Begin 00:53:19 Time Travel 00:54:19 Hidden Talent 00:54:48 Alternate Career 00:55:42 Advice to 18-Year-Old Roberto 00:56:29 Final Thoughts and Call to Action for Clinicians 00:57:00 Where to Find Dr. Malinow's Research (UCSD Website) 00:57:40 Sam's Closing Remarks 00:58:32 Episode Ending Thanks for listening Connect with Dr. Malinow: Website: https://biology.ucsd.edu/research/faculty/rmalinow Email: rmalinow@ucsd.edu 📝 Complete show notes with resources and links, please visit https://www.ketaminestartup.com/podcast/episode-059 Follow us on Linkedin Ketamine StartUp Website YouTube 🚀Want to fast track launching your ketamine clinic? If so, download our free checklist .

June 10, 2026Episode 581 hr 5 min

Episode 58 - From Finance to Purpose: Why Dr. Marc Smith Chose Healing Over Hedge Fund Trading

In this conversation, Dr. Marc Smith shares his journey from hedge fund trading in New York's financial district to building an integrated ketamine psychiatry practice in California. After three years in finance doing trading and sales, Dr. Smith made the bold decision to completely pivot his career toward medicine, driven by a desire for purpose and meaning that his financial career couldn't provide. Dr. Smith's path took him through Columbia University for medical school, followed by psychiatry residency at USC, where he discovered his passion for interventional treatments like TMS and ketamine therapy. His unique perspective, having worked in both profit-maximizing finance and purpose-driven healthcare, provides valuable insights into the challenges of maintaining ethical medical practice in an increasingly commercialized healthcare environment. Dr. Smith's practice, Clear Ketamine + Psychiatry, represents an integrated model where he personally handles psychiatric evaluation, preparation therapy, ketamine treatment administration, and post-treatment integration sessions. What You'll Learn in This Episode · Career transition insights - How Dr. Smith navigated the complete pivot from finance to medicine, including the challenges and rewards of choosing purpose over profit in healthcare · Mental health crisis analysis - Dr. Smith's perspective on factors contributing to rising depression, anxiety, and suicide rates, including social isolation, technology impacts, and healthcare access barriers · Treatment-resistant depression understanding - Why 30% of patients don't respond to traditional antidepressants and how ketamine offers a different mechanism through NMDA receptor antagonism and neuroplasticity induction · Integrated practice model - Dr. Smith's unique approach combining psychiatric evaluation, preparation therapy, ketamine administration, and integration sessions all under one provider rather than outsourcing components · Intentions versus goals framework - How to help patients set internal emotional states they're striving for (intentions) alongside specific, measurable functional outcomes (SMART goals) for comprehensive treatment planning · Ketamine as catalyst concept - Understanding how ketamine works like "jumpstarting a car" to improve mood and motivation, while ongoing therapy and lifestyle changes provide the maintenance needed for sustained improvement · Ethical practice building - Dr. Smith's mission to combat ketamine stigma through evidence-based protocols while addressing concerns about recreational associations and inappropriate use in the field · Private practice autonomy benefits - How owning your own practice allows values-driven decisions that may conflict with profit maximization, contrasting with private equity-driven healthcare models · Business building practical advice - The importance of talking to other practice owners, understanding it's a marathon not a sprint, and knowing your limitations to outsource effectively · Biopsychosocial treatment approach - Addressing biological, psychological, and social elements of mental health through medications, therapy, exercise, sleep, nutrition, social connection, and nature exposure Episode 58 show notes: 00:00:00 - Teaser: Profit vs. Purpose in Healthcare 00:00:35 - Episode Introduction 00:02:03 - Dr. Smith's Background: From East Coast to Medicine 00:02:30 - Career Transition: Three Years in Financial Industry 00:04:12 - Discovering Psychiatry Through Clinical Rotations 00:05:32 - Why Psychiatry: Deep Relationships and Human Connection 00:08:50 - Tools in the Toolbox: TMS, Ketamine, and Treatment Options 00:09:30 - The Leap: Stepping Away from Finance Success 00:11:17 - The Marble Metaphor: Chiseling Away What We Aren't 00:12:46 - Self-Actualization and Gratitude in Medicine 00:14:01 - USC Residency and Academic Reception of Ketamine 00:16:54 - Evidence-Based Medicine and the Slow Pace of Change 00:19:17 - Mental Health Crisis: Social Isolation and Technology 00:22:50 - The Invisible Nature of Mental Health Challenges 00:25:28 - Private Equity vs. Patient Care: The Business Tension 00:30:18 - Private Practice Autonomy and Values-Based Decisions 00:32:15 - Clear Ketamine + Psychiatry: The Integrated Model 00:36:11 - Treatment Protocol: Six Sessions with Therapy Integration 00:37:56 - Ketamine as Jumpstart: The Car Analogy 00:42:00 - Intentions vs. Goals: Internal States and SMART Outcomes 00:46:30 - Ethical Standards and Combating Ketamine Stigma 00:50:15 - Practice Building Advice: Talk to Other Providers 00:52:55 - Rapid Fire Questions: Book Recommendation 00:54:52 - Last Meal 00:55:52 - Pickleball Obsession and the Philosophy of the Game 00:56:50 - Time Travel 00:58:46 - Alternative Career 01:00:04 - Advice to 20-Year-Old Self 01:01:53 - Contact Information and Practice Details 01:03:03 - Final Thoughts: Gratitude and Evidence-Based Care 01:04:20 - Ending and Resources Thanks for listening Connect with Dr. Marc Smith at: Website: https://www.clearketapsych.com Instagram: @clearketapsych , @marcsmithmd LinkedIn: www.linkedin.com/in/marcsmithmd Google Maps: https://maps.app.goo.gl/GCHVy8q183c7WvfLA 📝 Complete show notes with resources and links, please visit www.ketaminestartup.com/podcast/episode-058 Follow us on Linkedin Ketamine StartUp Website YouTube 🚀Want to fast track launching your ketamine clinic? If so, download our free checklist .

May 26, 2026Episode 5758 min

Episode 57 - Beyond the Physical: Why Treating Chronic Pain Requires Healing the Whole Person with Dr. Michelle Weiner

In this conversation, Dr. Michelle Weiner shares her evolution from chief resident in interventional pain medicine to pioneering integrative practitioner who treats chronic pain through a biopsychosocial-spiritual lens. Double board-certified in Interventional Pain Medicine, Physical Medicine, and Rehabilitation, Dr. Weiner reveals why traditional procedure-focused approaches often fail chronic pain patients and how she discovered more effective ways to create lasting healing. Dr. Weiner's journey started with her background in nutritional science and athletics, leading her through physical medicine and rehabilitation before specializing in interventional pain. But day after day of performing procedures without truly connecting with patients left her frustrated and seeking deeper solutions. Her introduction to medical cannabis as chair of Florida's advisory committee opened her mind to personalized medicine and treating the whole person rather than just diagnosis codes. You'll hear about her unique approach to fibromyalgia, which she reframes as "central sensitization" to empower rather than limit patients. Dr. Weiner explains how trauma and adverse childhood experiences prime the nervous system for hyperreactivity, leading to chronic pain that becomes centrally mediated rather than structurally based. Her practice now integrates cannabis protocols, ketamine therapy, and comprehensive team-based care to address the root causes of both physical and emotional pain. Dr. Weiner also shares her personal ketamine experience during training, including a profound vision that later manifested in real life, demonstrating the spiritual dimension she now incorporates into treatment. You'll also hear practical insights about building an integrative practice, the importance of set and setting, and why true healing requires addressing the person with the diagnosis, not just the diagnosis itself. What You'll Learn in This Episode · Career transition insights - How Dr. Weiner evolved from high-volume interventional procedures to relationship-based integrative medicine and why she felt traditional approaches were "stringing patients along" · Central sensitization framework - Why she avoids the term "fibromyalgia" and instead explains central sensitization to empower patients and create hope rather than diagnostic limitations · Biopsychosocial-spiritual model - How incorporating the spiritual dimension creates awe-like effects and connections that traditional medicine misses, supported by neuroscience research · Medical cannabis integration - Her role on Florida's Medical Cannabis Advisory Committee and how cannabis opened conversations about personalized medicine and treating individual endocannabinoid systems · Trauma's role in chronic pain - How adverse childhood experiences and physical trauma prime the nervous system for hyperreactivity and chronic pain development · Practice building strategies - Practical advice about insurance credentialing, marketing to other providers, creating therapeutic environments, and building multidisciplinary teams · Set and setting importance - Why the physical environment, staff training, and patient preparation are crucial for maximizing ketamine therapy outcomes · Patient education approaches - How she explains that healing happens during the neuroplastic window after ketamine, not during the infusion itself, and why "more is not better" · Team-based care model - Working with coaches, therapists, and specialists trained in pain reprocessing therapy and somatic approaches to support comprehensive healing Episode 57 show notes: 00:00:00 - Teaser: Heart-Forward Medicine and True Passion 00:00:19 - Introduction and Dr. Weiner's Background Overview 00:02:00 - Educational Journey: From Nutrition Science to Pain Medicine 00:05:13 - Colleague Reactions to Non-Traditional Approach 00:08:37 - The Pivotal Moment: From Procedures to Purpose 00:11:04 - Cannabis Integration and Personalized Medicine Discovery 00:13:43 - Biopsychosocial Model and Pain Neuroscience Education 00:17:09 - Trauma Patterns and Chronic Pain Development 00:19:54 - Reframing Fibromyalgia as Central Sensitization 00:23:54 - Adding the Spiritual Dimension: Biopsychosocial-Spiritual Model 00:29:07 - Personal Ketamine Experience and Training Story 00:34:22 - Practice Building: From Employee to Business Owner 00:38:18 - Set and Setting: Creating Therapeutic Environments 00:41:48 - Patient Misconceptions and Education Strategies 00:47:08 - Rapid Fire Questions: 00:53:55 - Advice to 18-Year-Old Self 00:55:34 - Final Thoughts: Pain Complexity and Nervous System Healing 00:56:32 - Contact Information and Practice Locations 00:57:29 - Ending and Show Resources Connect with Dr. Weiner at: Website: www.drmichelleweiner.com LinkedIn: https://www.linkedin.com/in/michelle-weiner-do-mph-276b34b9 Facebook: https://www.facebook.com/drmichelleweiner/ 👉 Disclosure: Some of the links in these show notes are affiliate links. If you choose to make a purchase through them, we may earn a small commission at no additional cost to you. Thanks for supporting the podcast! Selected Links From the Episode: 📕 The Body Keeps the Score: Brain, Mind, and Body in the Healing of Trauma by Bessel van der Kolk M.D. 📘 The Awakened Brain: The New Science of Spirituality and Our Quest for an Inspired Life by Lisa Miller. 📝 Complete show notes with resources and links, please visit www.ketaminestartup.com/podcast/episode-057 Follow us on LinkedIn Ketamine StartUp Website YouTube 🚀Want to fast track launching your ketamine clinic? If so, download our free checklist .

May 5, 2026Episode 5614 min

Episode 56 - Breaking: Four Major Developments Reshaping Ketamine and Psychedelic Therapy

In this news roundup episode, we're covering four major developments that have emerged in recent months, all pointing toward increased accountability and oversight in the ketamine and psychedelic therapy space. This isn't our typical interview content - it's breaking news analysis that every provider in this community needs to understand. We start with the final chapter of the Matthew Perry case, where Jasveen Sangha, known as the "Ketamine Queen," received a 15-year federal prison sentence, while Dr. Salvador Plasencia was sentenced to 30 months for distributing ketamine outside proper medical supervision. Then we cover France becoming the first country to formally authorize IV racemic ketamine for adults in severe suicidal crisis, with rigorous hospital-based protocols that raise the bar for clinical standards globally. We continue with updates on Texas Medical Board's proposed ketamine regulations moving toward mandatory clinic registration and stricter oversight, followed by analysis of President Trump's executive order accelerating psychedelic research and creating new federal pathways for investigational compounds. We wrap up by connecting all four stories to show how legal consequences, international standards, state regulations, and federal policy are collectively signaling that oversight conversations are now happening at the highest levels of government and the field is entering a new era of accountability. What You'll Learn in This Episode · Legal accountability implications - How the Matthew Perry case sentencing creates new precedents for physician responsibility when ketamine treatment moves outside supervised clinical settings · International standards development - France's groundbreaking authorization of IV racemic ketamine for suicidal crisis and what their rigorous hospital-based protocols mean for global treatment standards · State regulatory evolution - Current status of Texas Medical Board's proposed ketamine regulations, including mandatory clinic registration and enhanced oversight requirements moving toward a June 2026 vote · Federal policy landscape changes - Analysis of Trump's executive order accelerating psychedelic research access and what new federal pathways mean for the broader psychedelic therapy field · Clinical framework implications - How France's high-surveillance psychiatric intervention model differs from wellness-oriented approaches and why this distinction matters for field credibility · Oversight trends analysis - Why legal consequences, international standards, state regulations, and federal policy are all pointing toward increased accountability requirements for providers · Risk assessment insights - Understanding where legitimate treatment can break down and how unmonitored use creates legal and ethical liability that traces back to prescribing physicians · Future preparation strategies - What these four developments collectively signal about where field standards are heading and how providers can prepare for increased scrutiny Episode 56 show notes: 00:06 Episode Introduction 01:28 Matthew Perry Case: The Final Sentence 03:47 France Authorizes IV Ketamine for Suicidal Crisis 07:03 Texas Medical Board Update: PKT Rules Still Pending 08:37 Trump Executive Order: Federal Fast-Track for Psychedelic Therapy 10:43 The REMS Advantage: What Regulatory-Ready Looks Like 12:34 Final Thoughts Thanks for listening Selected Links From the Episode: 📖Prefer to read? Check out our related blog post: Ketamine Therapy Regulations Spring 2026: Perry Sentencing, Texas Rules, France Authorization, and Federal Policy Shifts 🎧Listen to the full story about what’s about to happen in Texas: Episode 049 - Texas Medical Board Proposes Comprehensive Ketamine Therapy Regulations - What It Means for the Industry 📋 Episode references and sources 📝 Complete show notes with resources and links, please visit https://www.ketaminestartup.com/podcast/episode-056 Follow us on Linkedin Ketamine StartUp Website YouTube 🚀Want to fast track launching your ketamine clinic? If so, download our free checklist .

April 28, 2026Episode 551 hr 3 min

Episode 55 - Career Reinvention Success: Why Going Backwards Made Dr. Ruchir Gupta Advance

In this conversation, Dr. Ruchir Gupta shares his unconventional journey from established anesthesiologist to successful pain medicine entrepreneur. After 10 years of practicing anesthesia, he made the bold decision to return for a pain fellowship at Mayo Clinic, where he was older than most of his attendings. Dr. Gupta's story shows how strategic career reinvention can create competitive advantages in medicine. By combining his decade of anesthesia experience with pain medicine fellowship training, he identified a market opportunity that others overlooked: IV ketamine therapy for chronic pain patients. While other pain physicians were hesitant to offer ketamine infusions due to unfamiliarity with anesthetic protocols, Dr. Gupta's background made him uniquely qualified to bridge this gap. You'll hear about how his specialized fibromyalgia protocols achieves 80% success rates, his insights about monitoring standards including the "fifth vital sign" of proper patient follow up, and practical business advice about overcoming analysis paralysis. Dr. Gupta's journey from zero to building Mountain View Headache and Spine Institute offers valuable lessons for any medical professional considering practice ownership or career reinvention. His approach challenges common physician assumptions about entrepreneurship and shows how leveraging existing skills can lead to practice success. What You'll Learn in This Episode · Career reinvention strategy : how Dr. Gupta leveraged his anesthesia background to differentiate his pain practice and why returning to fellowship training became a competitive advantage rather than a setback · Physician entrepreneurship barriers : why medical professionals create mental obstacles around private practice that dentists, chiropractors, and other healthcare providers don't experience, and how to overcome this mindset · Clinical monitoring standards : detailed recommendations for ketamine infusion monitoring, including the importance of continuous EKG, pulse oximetry, and blood pressure monitoring for longer pain protocols · The "fifth vital sign" concept : why proper patient follow up and outcome measurement are essential for maintaining medical credibility and avoiding the "med spa" trap in ketamine therapy · Business development approach : practical strategies for practice growth including LinkedIn networking, physician education sessions, and building referral relationships with skeptical providers · Cross-disciplinary medicine benefits : why Dr. Gupta believes future physicians should combine multiple specialties or degrees to offer integrated approaches and differentiated services · Pain and mood disorder integration : clinical insights about treating patients with concurrent chronic pain and depression, including combination Spravato and ketamine protocols 📋 Professional Education Disclaimer: Content for licensed healthcare providers for educational purposes only. Does not constitute medical, legal, or business advice. Always consult qualified professionals for specific clinical and practice decisions. Key Takeaways · Reinvention requires strategic thinking, not just courage. Dr. Gupta's success came from identifying how his anesthesia background created competitive advantages in pain medicine, particularly with ketamine therapy that other providers avoided. · Physician mindset creates artificial entrepreneurship barriers. Unlike dentists and chiropractors who routinely start private practices, physicians have developed cultural resistance to entrepreneurship that isn't based on actual capability or market realities. · Clinical differentiation drives practice success. By offering IV ketamine when other pain doctors wouldn't, Dr. Gupta created a unique market position that generated demand for both ketamine services and traditional pain procedures. · Fibromyalgia responds differently than other conditions. His 80% success rate comes from recognizing that fibromyalgia requires different protocols than CRPS or depression, using shorter duration but potentially higher dose infusions. · Safety standards must match treatment complexity. Longer pain infusions require more comprehensive monitoring than depression protocols, including but not limited to continuous EKG and regular blood pressure checks every 15 minutes. · The "fifth vital sign" prevents med spa perception. Proper patient follow up with objective outcome measures maintains medical credibility and guides treatment decisions. · Cross-training creates competitive advantages. Combining anesthesia experience with pain medicine training allowed Dr. Gupta to offer services that single-specialty providers couldn't safely provide. · Business planning overcomes analysis paralysis. The hardest step is going from zero to one. Once you start a business plan, even imperfectly, the momentum builds and subsequent decisions become easier. · Multiple marketing channels compound results. Success came from combining LinkedIn professional networking, direct physician outreach, literature sharing, and educational presentations rather than relying on single strategies. Episode 55 show notes: 00:00:00 - Teaser: The Physician Mindset Problem 00:00:31 - Episode Introduction 00:02:14 - Dr. Gupta's Background 00:02:34 - Education: From Political Science to Choosing Anesthesia 00:06:14 - The Decision to Pursue Pain Fellowship 00:08:23 - Fellowship Experience: Being Older Than Attendings 00:09:51 - Turning Setback into Asset: The Ketamine Opportunity 00:13:21 - Starting Mountain View Headache and Spine 00:16:59 - The Physician Entrepreneurship Mindset Problem 00:21:37 - Building Referral Relationships and Practice Growth 00:25:18 - Pain Fellowship Training: What's Missing 00:29:35 - Fibromyalgia Protocols and Success Rates 00:34:27 - Pain vs Mood Disorder Treatment Approaches 00:36:17 - The "Fifth Vital Sign" and Medical Standards 00:40:45 - Monitoring Standards and Safety Considerations 00:50:06 - Business Planning: From Zero to One 00:54:17 - Marketing Strategies That Actually Work 00:56:05 - Rapid Fire Questions: What's on Your Desk 00:57:42 - Relaxation and Pickleball with His Son 00:58:04 - Hidden Talent: Writing Historical Fiction 00:59:22 - Time Travel: Ancient Rome 01:01:04 - Alternative Career: Finance and Building Businesses 01:01:28 - Contact Information 01:02:04 - Final Thoughts and Show Resources Thanks for listening 📝 Complete show notes with resources and links, please visit https://www.ketaminestartup.com/podcast/episode-055 Follow us on Linkedin Ketamine StartUp Website YouTube 🚀Want to fast track launching your ketamine clinic? If so, download our free checklist .